VIVIMEDLAB

Vivimed Labs Share Price

 

 

Start SIP in VIVIMEDLAB

Start SIP

Performance

  • Low
  • ₹9
  • High
  • ₹9
  • 52 Week Low
  • ₹7
  • 52 Week High
  • ₹29
  • Open Price₹9
  • Previous Close₹9
  • Volume585,092
  • 50 DMA₹10.51
  • 100 DMA₹10.57
  • 200 DMA₹11.34

Investment Returns

  • Over 1 Month -47.48%
  • Over 3 Month + 828%
  • Over 6 Month + 828%
  • Over 1 Year + 828%

Smart Investing Starts Here Start SIP with Vivimed Labs for Steady Growth!

Invest Now

Vivimed Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -3.2
  • PEG Ratio
  • -0.1
  • Market Cap Cr
  • 77
  • P/B Ratio
  • -1.1
  • Average True Range
  • 0.85
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.15
  • RSI
  • 45.57
  • MFI
  • 38.3

Vivimed Labs Financials

Vivimed Labs Technicals

EMA & SMA

Current Price
₹9.28
+ 0.44 (4.98%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹9.66
  • 50 Day
  • ₹10.51
  • 100 Day
  • ₹10.57
  • 200 Day
  • ₹11.34

Resistance and Support

9.24 Pivot Speed
  • R3 9.44
  • R2 9.36
  • R1 9.32
  • S1 9.20
  • S2 9.12
  • S3 9.08

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vivimed Labs has an operating revenue of Rs. 104.12 Cr. on a trailing 12-month basis. An annual revenue de-growth of -24% needs improvement, Pre-tax margin of -27% needs improvement, NULL The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 19 which is a POOR score indicating inconsistency in earnings, a RS Rating of 95 which is GREAT indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 81 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vivimed Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-13 Quarterly Results
2025-08-13 Quarterly Results, Pref. issue & A.G.M.
2025-05-30 Audited Results
2025-02-14 Quarterly Results
2025-01-10 Quarterly Results & Others To consider other business matters.

Vivimed Labs F&O

Vivimed Labs Shareholding Pattern

7.77%
0%
0%
1.64%
0%
65.06%
25.53%

About Vivimed Labs

  • NSE Symbol
  • VIVIMEDLAB
  • BSE Symbol
  • 532660
  • Managing Director
  • Mr. Santosh Varalwar
  • ISIN
  • INE526G01021

Similar Stocks to Vivimed Labs

Vivimed Labs FAQs

Vivimed Labs share price is ₹9 As on 02 February, 2026 | 02:24

The Market Cap of Vivimed Labs is ₹76.9 Cr As on 02 February, 2026 | 02:24

The P/E ratio of Vivimed Labs is -3.2 As on 02 February, 2026 | 02:24

The PB ratio of Vivimed Labs is -1.1 As on 02 February, 2026 | 02:24

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23